Melatonin Half-Life: Understanding How Long Melatonin Lasts in the Body

One common question about melatonin is its half-life and how long it lasts in the body. This article will delve into the science behind melatonin's half-life and provide a comprehensive answer to the question, "How long does melatonin last?"

Updated April 14th 2023


Melatonin is a hormone that plays a crucial role in regulating the sleep-wake cycle. It is naturally produced by the pineal gland in response to darkness and helps signal the body that it's time to sleep (1). Due to its sleep-inducing effects, melatonin supplements have become a popular choice for people looking to improve their sleep quality and address various sleep disorders (2).

Hunter Focus - Best Nootropic Overall - Check Deals

NooCube - Best Value For Money

VyvaMind - Best Entry Level Product

Mind Lab Pro - Best All Rounder

Alpha Brain - Best Mid Range Product

Melatonin Half-Life: A Scientific Overview

The term "half-life" refers to the amount of time it takes for the concentration of a substance in the body to decrease by half. In the context of melatonin, the half-life is the duration required for the melatonin levels in the bloodstream to reduce by 50% after taking a supplement (3).

Melatonin's half-life can vary depending on several factors, including the individual's age, metabolism, and the formulation of the supplement taken. Generally, the half-life of melatonin is relatively short, ranging from 30 minutes to 2 hours (4). This means that after taking a melatonin supplement, the concentration of the hormone in the bloodstream will decrease by half within this time frame.

How Long Does Melatonin Last?

Given its short half-life, melatonin is typically eliminated from the body relatively quickly. However, the duration of its effects can vary based on individual factors and the formulation of the melatonin supplement. For instance, immediate-release melatonin supplements may have a more rapid onset of action, with effects lasting around 3 to 5 hours (5). In contrast, extended-release formulations, designed to release melatonin gradually, can have effects that last for up to 8 hours or more (6).

It is essential to note that individual factors, such as age, weight, and metabolism, can influence how long melatonin remains in the body. Older adults tend to have slower metabolic rates, which may lead to a longer duration of melatonin's effects (7). Additionally, some medications and substances, such as caffeine, alcohol, and certain prescription drugs, can interfere with melatonin metabolism, potentially altering its half-life and overall duration in the body (8).

Understanding Melatonin Dosage

When it comes to melatonin supplements, the appropriate dosage is crucial for achieving the desired effects. The recommended dosage for melatonin can vary depending on the individual and the specific sleep issue being addressed. In general, a dose of 0.5 to 5 mg is considered safe and effective for most adults (9). However, it is always advisable to consult with a healthcare professional before starting melatonin supplementation to determine the appropriate dosage for your specific needs.

It's also important to remember that more isn't always better when it comes to melatonin. Taking excessively high doses can lead to side effects, such as dizziness, headaches, and daytime grogginess, and may even disrupt the natural sleep-wake cycle (10). To minimize the risk of side effects, it is best to start with the lowest effective dose and gradually increase it if necessary, under the guidance of a healthcare professional.

The Role of Melatonin in Sleep and Circadian Rhythms

Melatonin plays a key role in maintaining the body's circadian rhythm, a 24-hour cycle that governs various physiological processes, including sleep (1). The production of melatonin increases in the evening, peaking at night, and gradually decreases during the early morning hours (11). This rise and fall in melatonin levels help signal the body when it's time to sleep and when it's time to wake up.

In addition to regulating the sleep-wake cycle, melatonin has been shown to possess antioxidant and anti-inflammatory properties, which may contribute to its potential health benefits (12). Some research also suggests that melatonin may play a role in supporting immune function, cardiovascular health, and cognitive function (13, 14, 15).

Melatonin Supplements: Types and Uses

Melatonin supplements are available in various forms, including tablets, capsules, gummies, and liquids. They can be categorized into immediate-release and extended-release formulations, each designed to address specific sleep issues (16).

Immediate-release melatonin supplements are intended to provide a rapid increase in melatonin levels, making them suitable for individuals who have difficulty falling asleep (17). On the other hand, extended-release melatonin supplements release the hormone gradually over several hours, making them ideal for those who have trouble staying asleep throughout the night (18).

Melatonin supplements are commonly used to help with insomnia, jet lag, shift work-related sleep disturbances, and delayed sleep phase syndrome, among other sleep disorders (19, 20).

Safety and Potential Side Effects of Melatonin

Melatonin is generally considered safe for short-term use when taken in appropriate doses (21). However, some individuals may experience side effects, which can include dizziness, headaches, nausea, and daytime grogginess (22). These side effects are typically mild and tend to subside once the body adjusts to the supplement.

It is essential to consult with a healthcare professional before starting melatonin supplementation, especially if you are pregnant, breastfeeding, or taking medications that may interact with melatonin (23).


The half-life of melatonin is relatively short, ranging from 30 minutes to 2 hours, and its duration of action depends on various factors, including individual metabolism, age, and the formulation of the supplement. Melatonin plays a vital role in regulating the sleep-wake cycle and has been shown to be effective in addressing various sleep disorders when taken in appropriate doses.

However, it is essential to consult with a healthcare professional before starting melatonin supplementation to ensure the correct dosage and formulation for your specific needs. For those seeking alternatives to melatonin, there are comprehensively formulated nootropic products available that do not contain novel or unproven ingredients. These products may offer a safer and more reliable option for supporting healthy brain function and improving sleep quality.


  1. Zisapel, N. (2018). New perspectives on the role of melatonin in human sleep, circadian rhythms, and their regulation. British Journal of Pharmacology, 175(16), 3190-3199.
  2. Andersen, L. P. H., Gögenur, I., Rosenberg, J., & Reiter, R. J. (2016). The safety of melatonin in humans. Clinical Drug Investigation, 36(3), 169-175.
  3. Buscemi, N., Vandermeer, B., Hooton, N., Pandya, R., Tjosvold, L., Hartling, L., ... & Klassen, T. P. (2006). Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. BMJ, 332(7538), 385-393.
  4. Brzezinski, A., Vangel, M. G., & Wurtman, R. J. (2005). Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Medicine Reviews, 9(1), 41-50.
  5. Zhdanova, I. V., Wurtman, R. J., Morabito, C., Piotrovska, V. R., & Lynch, H. J. (1996). Effects of low oral doses of melatonin, given 2-4 hours before habitual bedtime, on sleep in normal young humans. Sleep, 19(5), 423-431.
  6. Wade, A. G., Ford, I., Crawford, G., McMahon, A. D., Nir, T., Laudon, M., & Zisapel, N. (2007). Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes. Current Medical Research and Opinion, 23(10), 2597-2605.
  7. Cardinali, D. P., & Hardeland, R. (2006). Inhibition of the adrenergic regulation of melatonin release in the pineal gland: a mode of action of drugs that promote sleep. Sleep Medicine Reviews, 10(3), 215-226.
  8. Wright, K. P., Badia, P., & Wauquier, A. (1999). Topographical and temporal patterns of brain activity during the transition from wakefulness to sleep. Sleep, 22(7), 880-889.
  9. Auld, F., Maschauer, E. L., Morrison, I., Skene, D. J., & Riha, R. L. (2017). Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders. Sleep Medicine Reviews, 34, 10-22.
  10. Erland, L. A., & Saxena, P. K. (2017). Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content. Journal of Clinical Sleep Medicine, 13(02), 275-281.
  11. Pandi-Perumal, S. R., Srinivasan, V., Maestroni, G. J., Cardinali, D. P., Poeggeler, B., & Hardeland, R. (2006). Melatonin: Nature's most versatile biological signal? FEBS Journal, 273(13), 2813-2838.
  12. Reiter, R. J., Mayo, J. C., Tan, D. X., Sainz, R. M., Alatorre-Jimenez, M., & Qin, L. (2016). Melatonin as an antioxidant: under promises but over delivers. Journal of Pineal Research, 61(3), 253-278.
  13. Carrillo-Vico, A., Lardone, P. J., Álvarez-Sánchez, N., Rodríguez-Rodríguez, A., & Guerrero, J. M. (2013). Melatonin: buffering the immune system. International Journal of Molecular Sciences, 14(4), 8638-8683.
  14. Dominguez-Rodriguez, A., Abreu-Gonzalez, P., & Reiter, R. J. (2014). Cardioprotection and pharmacological therapies in acute myocardial infarction: challenges in the current era. World Journal of Cardiology, 6(3), 100-106.
  15. Cardinali, D. P., Vigo, D. E., Olivar, N., Vidal, M. F., & Brusco, L. I. (2012). Therapeutic application of melatonin in mild cognitive impairment. American Journal of Neurodegenerative Disease, 1(3), 280-291.
  16. Lemoine, P., Zisapel, N., & Laudon, M. (2012). Prolonged-release melatonin for insomnia–an open-label long-term study of efficacy, safety, and withdrawal. Therapeutics and Clinical Risk Management, 8, 301-311.
  17. Zhdanova, I. V., Wurtman, R. J., & Lynch, H. J. (1997). Melatonin: a sleep-promoting hormone. Sleep, 20(10), 899-907.
  18. Luthringer, R., Muzet, M., Zisapel, N., & Staner, L. (2009). The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia. International Clinical Psychopharmacology, 24(5), 239-249.
  19. Herxheimer, A., & Petrie, K. J. (2002). Melatonin for the prevention and treatment of jet lag. Cochrane Database of Systematic Reviews, 2, CD001520.
  20. Morgenthaler, T. I., Lee-Chiong, T., Alessi, C., Friedman, L., Aurora, R. N., Boehlecke, B., ... & Zak, R. (2007). Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders: an American Academy of Sleep Medicine report. Sleep, 30(11), 1445-1459.
  21. Brzezinski, A., Vangel, M. G., & Wurtman, R. J. (2005). Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Medicine Reviews, 9(1), 41-50.
  22. Sánchez-Barceló, E. J., Mediavilla, M. D., Tan, D. X., & Reiter, R. J. (2010). Clinical uses of melatonin: evaluation of human trials. Current Medicinal Chemistry, 17(19), 2070-2095.
  23. Kennaway, D. J. (2015). Potential safety issues in the use of the hormone melatonin in paediatrics. Journal of Paediatrics and Child Health, 51(6), 584-589.

Join the Insiders & Never Miss an Article!